News - Myeloma Patients Europe

Latest News

The American Society of Clinical Oncology Annual Meeting (ASCO2020) is the largest and one of the most important congresses for the oncology community. Many myeloma and AL amyloidosis updates were presented at this congress which…

MPE COVID-19 Scholarship Programme

July 14, 2020

As part of the work that Myeloma Patients Europe (MPE) is doing to provide members with support during the COVID-19 pandemic, MPE is extending the MPE Scholarship and Capacity Building Programme. Through this extension,…

EHA 2020 – Subcutaneous daratumumab shows improved clinical outcomes in AL amyloidosis

June 14, 2020

New data of the ANDROMEDA clinical trial has been presented today in the late breaking session at the 25th European Hematology Association (EHA) Annual Congress which is happening virtual from 11 to 21 June. This study evaluates…

FDA Refusal to File letter for Idecabtagene Vicleucel (ide-cel, bb2121) for the treatment of myeloma patients

May 14, 2020

Bristol Myers Squibb (BMS) and bluebird bio, Inc have announced that the companies received a Refusal to File letter from the U.S. Food and Drug Administration (FDA) regarding the Biologics License Application (BLA) for…

MPE webinar on the impact of myeloma and AL amyloidosis in carers. What are the issues and challenges?

May 8, 2020

Myeloma Patients Europe (MPE) will hold a webinar on the impact of myeloma and AL amyloidosis in carers on Wednesday 20 May 2020 from 18:00 – 19:00 CET. The webinar will be given by…

MPE webinar on personalised medicines in myeloma and AL amyloidosis

April 28, 2020

Myeloma Patients Europe (MPE) will hold a webinar on personalised medicines in myeloma and AL amyloidosis on Wednesday 6 May 2020 from 18:00 – 19:00 CET.

New clinical trial to evaluate the myeloma drug selinexor as potential treatment for patients with COVID-19

April 14, 2020

The pharmaceutical company, Karyopharm Therapeutics has announced plans to initiate a global randomized clinical trial for low dose oral selinexor in hospitalized patients with severe COVID-19 (coronavirus). Selinexor, marketed as XPOVIO®, is currently approved at…

November

December 2024

January

MO
TU
WE
TH
FR
SA
SU

25
26
27
28
29
30
1

2
3
4
5
6
7
8

9
10
11
12
13
14
15

16
17
18
19
20
21
22

23
24
25
26
27
28
29

30
31
1
2
3
4
5

Events for December

31st

No Events

Latest News

December 2024

Events for December

1st

Events for December

2nd

Events for December

3rd

Events for December

4th

Events for December

5th

Events for December

6th

Events for December

7th

Events for December

8th

Events for December

9th

Events for December

10th

Events for December

11th

Events for December

12th

Events for December

13th

Events for December

14th

Events for December

15th

Events for December

16th

Events for December

17th

Events for December

18th

Events for December

19th

Events for December

20th

Events for December

21st

Events for December

22nd

Events for December

23rd

Events for December

24th

Events for December

25th

Events for December

26th

Events for December

27th

Events for December

28th

Events for December

29th

Events for December

30th

Events for December

31st

Myeloma Patients Europe AISBL

PopUp